Clinical Trial Update: A Phase 1, Randomized, Placebo-Controlled, Ascending Cohort, Dose Escalation Study in Normal Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 randomized, placebo-controlled, dose-escalation study in healthy volunteers sponsored by GlaxoSmithKline to evaluate an investigational drug for irritab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• GSK IBS candidate (investigational)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Irritable Bowel Syndrome | Phase 1 | Status: COMPLETED